MOROSON BA[au] - Search Results

Year	Number of Results
1977	1
1979	3
1980	2
1981	2
1982	1
1983	2
1984	1
1985	4
1986	1
1987	4
1988	1
1989	2
1990	1
1991	2
1992	1
1993	1
1995	1
1996	1
1997	1
1998	1
2022	0

1

Methotrexate resistant cells as targets for selective chemotherapy.

Bertino JR, Mini E, Sobrero A, Moroson BA, Love T, Jastreboff M, Carmen M, Srimatkandada S, Dube S. Bertino JR, et al. Among authors: moroson ba. Adv Enzyme Regul. 1985;24:3-11. doi: 10.1016/0065-2571(85)90066-4. Adv Enzyme Regul. 1985. PMID: 3915186 Review.

2

Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemia.

Mini E, Coronnello M, Carotti S, Gerli A, Pesciullesi A, Moroson BA, Mazzei T, Periti P, Bertino JR. Mini E, et al. Among authors: moroson ba. J Chemother. 1990 Feb;2 Suppl 1:17-27. doi: 10.1080/1120009x.1990.11739000. J Chemother. 1990. PMID: 2142214 Review.

3

Gene amplification and altered enzymes as mechanisms for the development of drug resistance.

Bertino JR, Carman MD, Weiner HL, Cashmore A, Moroson BA, Srimatkandada S, Schornagel JH, Medina WD, Dube SK. Bertino JR, et al. Among authors: moroson ba. Cancer Treat Rep. 1983 Oct;67(10):901-4. Cancer Treat Rep. 1983. PMID: 6354438 Review.

4

Structure and functional relationships in human pur H.

Beardsley GP, Rayl EA, Gunn K, Moroson BA, Seow H, Anderson KS, Vergis J, Fleming K, Worland S, Condon B, Davies J. Beardsley GP, et al. Among authors: moroson ba. Adv Exp Med Biol. 1998;431:221-6. doi: 10.1007/978-1-4615-5381-6_43. Adv Exp Med Biol. 1998. PMID: 9598063

5

LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes.

Shih C, Chen VJ, Gossett LS, Gates SB, MacKellar WC, Habeck LL, Shackelford KA, Mendelsohn LG, Soose DJ, Patel VF, Andis SL, Bewley JR, Rayl EA, Moroson BA, Beardsley GP, Kohler W, Ratnam M, Schultz RM. Shih C, et al. Among authors: moroson ba. Cancer Res. 1997 Mar 15;57(6):1116-23. Cancer Res. 1997. PMID: 9067281

6

5,10-Dideazatetrahydrofolic acid (DDATHF) transport in CCRF-CEM and MA104 cell lines.

Pizzorno G, Cashmore AR, Moroson BA, Cross AD, Smith AK, Marling-Cason M, Kamen BA, Beardsley GP. Pizzorno G, et al. Among authors: moroson ba. J Biol Chem. 1993 Jan 15;268(2):1017-23. J Biol Chem. 1993. PMID: 8419310 Free article.

7

Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines.

Mini E, Moroson BA, Franco CT, Bertino JR. Mini E, et al. Among authors: moroson ba. Cancer Res. 1985 Jan;45(1):325-30. Cancer Res. 1985. PMID: 3855284

8

Molecular and karyological analysis of methotrexate-resistant and -sensitive human leukemic CCRF-CEM cells.

Mini E, Srimatkandada S, Medina WD, Moroson BA, Carman MD, Bertino JR. Mini E, et al. Among authors: moroson ba. Cancer Res. 1985 Jan;45(1):317-24. Cancer Res. 1985. PMID: 3855283

9

A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis.

Beardsley GP, Moroson BA, Taylor EC, Moran RG. Beardsley GP, et al. Among authors: moroson ba. J Biol Chem. 1989 Jan 5;264(1):328-33. J Biol Chem. 1989. PMID: 2909524 Free article.

10

Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.

Pizzorno G, Moroson BA, Cashmore AR, Russello O, Mayer JR, Galivan J, Bunni MA, Priest DG, Beardsley GP. Pizzorno G, et al. Among authors: moroson ba. Cancer Res. 1995 Feb 1;55(3):566-73. Cancer Res. 1995. PMID: 7834626

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results